Accelerating Transformation in Global Regulatory Affairs

Background: 

Recently, a top-tier biopharmaceutical company’s Global Regulatory Affairs (GRA) division launched a strategic transition to shift regulatory operations from one vendor to another. The move was part of a broader sourcing strategy and required both speed and flawless execution. A consulting partner overseeing the transformation brought in Osprey Life Sciences to lead and stabilize the transition – initially supporting the sourcing program and later continuing through enterprise-critical efforts, including the adoption of a new regulatory platform. 

Challenge:

The engagement involved two overlapping programs, each with rising levels of complexity and visibility: 

1. Strategic Sourcing Transition 

• Transitioned regulatory operations across fifteen global workstreams 

• Coordinated across three organizational entities 

• Completed full transition in just four months 

• Onboarded over 430 personnel across multiple regions 

• Established foundational governance and risk management frameworks 

2. Regulatory Platform Adoption Program 

• Enabled enterprise-wide adoption of a new regulatory data and process platform 

• Aligned and standardized processes 

• Ensured timely system integration 

• Maintained pre-planned Go-Live date  

Solution:

Osprey deployed a cross-functional team experienced in large-scale transformation. The approach spanned leadership, execution, and business adoption: 

Leadership & Planning 

• Delivered clear, strategic leadership with synchronized, cross-team timelines 

• Developed and executed planning across 15 interdependent workstreams 

• Integrated systems, processes, and people into a cohesive operational model 

Execution and Stabilization 

• Completed full functional handover ahead of schedule (within four months) 

• Integrated new global workforce efficiently through coordinated onboarding 

• Established real-time metrics, risk frameworks, and governance tools 

• Developed scalable portfolio reporting structures for the future 

Business Adoption of New Regulatory Platform 

• Led business-wide change management and stakeholder alignment 

• Prioritized operational readiness and compliance 

• Maintained a focus on data integrity, user training, and business continuity 

Initiation 

• Osprey was brought in due to a strong reputation for delivering results in high-pressure program environments. Initial success led to a deeper engagement, expanded responsibilities, and increasing recognition as a trusted transformation advisor. 

Key Stakeholders 

• Regulatory Affairs leadership 

• Business process owners and operational teams 

• Change management, IT, and portfolio management stakeholders 

Results & Impact 

• Delivered a full transition in four months (versus a typical 9-to-12-month window) 

• Enabled large-scale global employee onboarding 

• Received a six-month extension to ensure stability and operational continuity 

• Achieved on-time Go-Live date for the regulatory platform  

• Assigned additional PPMO and portfolio oversight responsibilities 

• Implemented long-term governance and metrics frameworks 

Challenges Overcome 

• Compressed delivery timelines 

• Multi-vendor and multi-company coordination 

• Legacy systems and process complexity 

• Large-scale global onboarding and training 

Results:

Osprey Life Sciences delivered under high-stakes conditions, providing not only tactical execution but also strategic leadership. From rapid sourcing transitions to digital transformation, Osprey’s contributions helped drive sustainable change and long-term value in global regulatory operations.

Client Feedback:

The client recognized Osprey as a trusted partner delivering strong governance, critical thinking, and reliable execution under pressure.